Dr. Tamminga holds the Lou and Ellen McGinley Distinguished Chair and the McKenzie Chair in Psychiatry at the University of Texas Southwestern Medical School and is the Chairman of the Department of Psychiatry and the Chief of the Translational Neuroscience Division in Schizophrenia at UTSW.   She received her M.D. degree from Vanderbilt University and completed residency training in psychiatry at the University of Chicago.  She served on the University of Chicago faculty from 1975 to 1979 and moved to the NINDS for training in Neurology in 1978.   After joining the faculty at the University of Maryland Medical School in 1979, she practiced research, clinical care and teaching there until joining the faculty at UT Southwestern Medical School in 2003.
<br />
<br />Dr. Tamminga is currently a member of NIMHs National Advisory Board and has served on the Board of Scientific Counselors of the National Institute of Mental Health and the National Institute of Drug Abuse, as Council member and President of the American College of Neuropsychopharmacology, as a Member and Chair of the Psychopharmacological Drugs Advisory Committee of the FDA, as well as consultant for the Orphan Products Development Review Group, FDA.&nbsp; She is a member of the Advisory Board of the Brain and Behavioral Research Foundation (NARSAD).&nbsp;&nbsp; She is currently the Deputy Editor of the American Journal of Psychiatry and on the editorial board of several other journals in the field.&nbsp;&nbsp; Dr. Tamminga was elected to the Institute of Medicine of the National Academies of Sciences in 1998 and has served on several IOM committees in that capacity.
<br />